Cargando…
Correlation of PD-L1 expression on tumour cells between diagnostic biopsies and surgical specimens of lung cancer in real life with respect to biopsy techniques and neoadjuvant treatment
PURPOSES: Programmed death-ligand 1 (PD-L1) testing is performed mainly on biopsy specimens in patients with advanced lung cancer. It is questionable whether the small amount of tissue analysed in biopsies may represent the true PD-L1 expression of a tumour. METHODS: In this retrospective study, PD-...
Autores principales: | Gompelmann, D., Sinn, K., Brugger, J., Bernitzky, D., Mosleh, B., Prosch, H., Geleff, S., Blessing, A., Tiefenbacher, A., Hoetzenecker, K., Idzko, M., Hoda, M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097774/ https://www.ncbi.nlm.nih.gov/pubmed/35708777 http://dx.doi.org/10.1007/s00432-022-04080-4 |
Ejemplares similares
-
Impact of fibrinogen levels and modified Glasgow prognostic score on survival of stage III/N2 non-small cell lung cancer patients treated with neoadjuvant therapy and radical resection
por: Sinn, Katharina, et al.
Publicado: (2022) -
Impact of persistent D-dimer elevation following recovery from COVID-19
por: Lehmann, Antje, et al.
Publicado: (2021) -
Comparison of pulmonary function test, diffusion capacity, blood gas analysis and CT scan in patients with and without persistent respiratory symptoms following COVID-19
por: Lehmann, Antje, et al.
Publicado: (2022) -
Proportion of biopsy specimens containing a tumor when compared to all biopsy specimens by transbronchial biopsy
por: Takemoto, Shinnosuke, et al.
Publicado: (2023) -
Evaluation of PD-L1 and tumor infiltrating lymphocytes in paired pretreatment biopsies and post neoadjuvant chemotherapy surgical specimens of breast carcinoma
por: Hoffmann, Lucas Grecco, et al.
Publicado: (2021)